Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

473 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer.
Ahmed HU, Moore C, Emberton M. Ahmed HU, et al. Among authors: emberton m. Surg Oncol. 2009 Sep;18(3):219-32. doi: 10.1016/j.suronc.2009.02.002. Epub 2009 Mar 5. Surg Oncol. 2009. PMID: 19268572 Review.
A rare tumour in the pelvis presenting with lower urinary symptoms: 'sclerosing epithelioid fibrosarcoma'.
Arya M, Garcia-Montes F, Patel HR, Emberton M, Mundy AR. Arya M, et al. Among authors: emberton m. Eur J Surg Oncol. 2001 Feb;27(1):121-2. doi: 10.1053/ejso.2000.1023. Eur J Surg Oncol. 2001. PMID: 11237504 No abstract available.
Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study.
Nathan TR, Whitelaw DE, Chang SC, Lees WR, Ripley PM, Payne H, Jones L, Parkinson MC, Emberton M, Gillams AR, Mundy AR, Bown SG. Nathan TR, et al. Among authors: emberton m. J Urol. 2002 Oct;168(4 Pt 1):1427-32. doi: 10.1097/01.ju.0000030000.81684.7e. J Urol. 2002. PMID: 12352410 Clinical Trial.
Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?
Moore CM, Hoh IM, Bown SG, Emberton M. Moore CM, et al. Among authors: emberton m. BJU Int. 2005 Oct;96(6):754-8. doi: 10.1111/j.1464-410X.2005.05709.x. BJU Int. 2005. PMID: 16153193 Review. No abstract available.
Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
Moore CM, Nathan TR, Lees WR, Mosse CA, Freeman A, Emberton M, Bown SG. Moore CM, et al. Among authors: emberton m. Lasers Surg Med. 2006 Jun;38(5):356-63. doi: 10.1002/lsm.20275. Lasers Surg Med. 2006. PMID: 16392142 Clinical Trial.
The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy.
Uchida T, Illing RO, Cathcart PJ, Emberton M. Uchida T, et al. Among authors: emberton m. BJU Int. 2006 Oct;98(4):770-2. doi: 10.1111/j.1464-410X.2006.06369.x. Epub 2006 Jul 28. BJU Int. 2006. PMID: 16879448
To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?
Uchida T, Illing RO, Cathcart PJ, Emberton M. Uchida T, et al. Among authors: emberton m. BJU Int. 2006 Sep;98(3):537-9. doi: 10.1111/j.1464-410X.2006.06297.x. BJU Int. 2006. PMID: 16925749
Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: A proposed standard for the conduct of therapy.
Illing RO, Leslie TA, Kennedy JE, Calleary JG, Ogden CW, Emberton M. Illing RO, et al. Among authors: emberton m. BJU Int. 2006 Dec;98(6):1187-92. doi: 10.1111/j.1464-410X.2006.06509.x. BJU Int. 2006. PMID: 17125476
Sonablate-500: transrectal high-intensity focused ultrasound for the treatment of prostate cancer.
Illing R, Emberton M. Illing R, et al. Among authors: emberton m. Expert Rev Med Devices. 2006 Nov;3(6):717-29. doi: 10.1586/17434440.3.6.717. Expert Rev Med Devices. 2006. PMID: 17280536 Review.
An algorithm for managing the failure of external beam radiotherapy in prostate cancer.
Dudderidge T, Payne H, Emberton M. Dudderidge T, et al. Among authors: emberton m. BJU Int. 2007 Sep;100(3):518-27. doi: 10.1111/j.1464-410X.2007.06999.x. Epub 2007 Jun 15. BJU Int. 2007. PMID: 17573894 Review.
473 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback